1009 related articles for article (PubMed ID: 26838600)
21. Triggering the adaptive immune system with commensal gut bacteria protects against insulin resistance and dysglycemia.
Pomié C; Blasco-Baque V; Klopp P; Nicolas S; Waget A; Loubières P; Azalbert V; Puel A; Lopez F; Dray C; Valet P; Lelouvier B; Servant F; Courtney M; Amar J; Burcelin R; Garidou L
Mol Metab; 2016 Jun; 5(6):392-403. PubMed ID: 27257599
[TBL] [Abstract][Full Text] [Related]
22. The aggravation of arthritis by periodontitis is dependent of IL-17 receptor A activation.
de Aquino SG; Talbot J; Sônego F; Turato WM; Grespan R; Avila-Campos MJ; Cunha FQ; Cirelli JA
J Clin Periodontol; 2017 Sep; 44(9):881-891. PubMed ID: 28498497
[TBL] [Abstract][Full Text] [Related]
23. Transient Expression of IL-17A in Foxp3 Fate-Tracked Cells in
Bittner-Eddy PD; Fischer LA; Costalonga M
Front Immunol; 2020; 11():677. PubMed ID: 32391008
[TBL] [Abstract][Full Text] [Related]
24. Gingival lymphatic drainage protects against Porphyromonas gingivalis-induced bone loss in mice.
Mkonyi LE; Bletsa A; Bolstad AI; Bakken V; Wiig H; Berggreen E
Am J Pathol; 2012 Sep; 181(3):907-16. PubMed ID: 22901755
[TBL] [Abstract][Full Text] [Related]
25. Porphyromonas gulae Has Virulence and Immunological Characteristics Similar to Those of the Human Periodontal Pathogen Porphyromonas gingivalis.
Lenzo JC; O'Brien-Simpson NM; Orth RK; Mitchell HL; Dashper SG; Reynolds EC
Infect Immun; 2016 Sep; 84(9):2575-85. PubMed ID: 27354442
[TBL] [Abstract][Full Text] [Related]
26. Serum antibodies of periodontitis patients compared to the lipopolysaccharides of Porphyromonas gingivalis and Fusobacterium nucleatum.
Onoue S; Imai T; Kumada H; Umemoto T; Kaca W; Isshiki Y; Kaneko A; Kawahara K
Microbiol Immunol; 2003; 47(1):51-5. PubMed ID: 12636253
[TBL] [Abstract][Full Text] [Related]
27. The r40-kDa outer membrane protein human monoclonal antibody protects against Porphyromonas gingivalis-induced bone loss in rats.
Hamada N; Watanabe K; Tahara T; Nakazawa K; Ishida I; Shibata Y; Kobayashi T; Yoshie H; Abiko Y; Umemoto T
J Periodontol; 2007 May; 78(5):933-9. PubMed ID: 17470029
[TBL] [Abstract][Full Text] [Related]
28. Oral administration of all-trans retinoic acid suppresses experimental periodontitis by modulating the Th17/Treg imbalance.
Wang L; Wang J; Jin Y; Gao H; Lin X
J Periodontol; 2014 May; 85(5):740-50. PubMed ID: 23952076
[TBL] [Abstract][Full Text] [Related]
29. Immunization with malondialdehyde-modified low-density lipoprotein (LDL) reduces atherosclerosis in LDL receptor-deficient mice challenged with Porphyromonas gingivalis.
Turunen SP; Kummu O; Wang C; Harila K; Mattila R; Sahlman M; Pussinen PJ; Hörkkö S
Innate Immun; 2015 May; 21(4):370-85. PubMed ID: 25134521
[TBL] [Abstract][Full Text] [Related]
30. Periodontal and systemic responses in various mice models of experimental periodontitis: respective roles of inflammation duration and Porphyromonas gingivalis infection.
Saadi-Thiers K; Huck O; Simonis P; Tilly P; Fabre JE; Tenenbaum H; Davideau JL
J Periodontol; 2013 Mar; 84(3):396-406. PubMed ID: 22655910
[TBL] [Abstract][Full Text] [Related]
31. Mucosal Langerhans Cells Promote Differentiation of Th17 Cells in a Murine Model of Periodontitis but Are Not Required for Porphyromonas gingivalis-Driven Alveolar Bone Destruction.
Bittner-Eddy PD; Fischer LA; Kaplan DH; Thieu K; Costalonga M
J Immunol; 2016 Aug; 197(4):1435-46. PubMed ID: 27402698
[TBL] [Abstract][Full Text] [Related]
32. Tamibarotene modulates the local immune response in experimental periodontitis.
Jin Y; Wang L; Liu D; Lin X
Int Immunopharmacol; 2014 Dec; 23(2):537-45. PubMed ID: 25448496
[TBL] [Abstract][Full Text] [Related]
33.
Bartnicka D; Gonzalez-Gonzalez M; Sykut J; Koziel J; Ciaston I; Adamowicz K; Bras G; Zawrotniak M; Karkowska-Kuleta J; Satala D; Kozik A; Zyla E; Gawron K; Lazarz-Bartyzel K; Chomyszyn-Gajewska M; Rapala-Kozik M
Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32183255
[No Abstract] [Full Text] [Related]
34. Complement Involvement in Periodontitis: Molecular Mechanisms and Rational Therapeutic Approaches.
Hajishengallis G; Maekawa T; Abe T; Hajishengallis E; Lambris JD
Adv Exp Med Biol; 2015; 865():57-74. PubMed ID: 26306443
[TBL] [Abstract][Full Text] [Related]
35. Periodontal pathogens invade gingiva and aortic adventitia and elicit inflammasome activation in αvβ6 integrin-deficient mice.
Velsko IM; Chukkapalli SS; Rivera-Kweh MF; Zheng D; Aukhil I; Lucas AR; Larjava H; Kesavalu L
Infect Immun; 2015 Dec; 83(12):4582-93. PubMed ID: 26371120
[TBL] [Abstract][Full Text] [Related]
36. Serum C-reactive protein and immunoglobulin G antibodies to periodontal pathogens may be effect modifiers of periodontitis and hyperglycemia.
Choi YH; McKeown RE; Mayer-Davis EJ; Liese AD; Song KB; Merchant AT
J Periodontol; 2014 Sep; 85(9):1172-81. PubMed ID: 24410292
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of the host response in various models of induced periodontal disease in mice.
de Molon RS; de Avila ED; Boas Nogueira AV; Chaves de Souza JA; Avila-Campos MJ; de Andrade CR; Cirelli JA
J Periodontol; 2014 Mar; 85(3):465-77. PubMed ID: 23805811
[TBL] [Abstract][Full Text] [Related]
38. hTERT Peptide Fragment GV1001 Prevents the Development of
Chen W; Kim SY; Lee A; Kim YJ; Chang C; Ton-That H; Kim R; Kim S; Park NH
Int J Mol Sci; 2024 Jun; 25(11):. PubMed ID: 38892314
[TBL] [Abstract][Full Text] [Related]
39. Odanacatib, A Cathepsin K-Specific Inhibitor, Inhibits Inflammation and Bone Loss Caused by Periodontal Diseases.
Hao L; Chen J; Zhu Z; Reddy MS; Mountz JD; Chen W; Li YP
J Periodontol; 2015 Aug; 86(8):972-83. PubMed ID: 25879791
[TBL] [Abstract][Full Text] [Related]
40. Oral Porphyromonas gingivalis translocates to the liver and regulates hepatic glycogen synthesis through the Akt/GSK-3β signaling pathway.
Ishikawa M; Yoshida K; Okamura H; Ochiai K; Takamura H; Fujiwara N; Ozaki K
Biochim Biophys Acta; 2013 Dec; 1832(12):2035-43. PubMed ID: 23899607
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
